Reply Letter - Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 May;26(9):3061. doi: 10.26355/eurrev_202205_28722.NO ABSTRACTPMID:35587055 | DOI:10.26355/eurrev_202205_28722 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - May 19, 2022 Category: Drugs & Pharmacology Authors: J F de Carvalho L C Behrmann Martins A F Cardoso Y Shoenfeld Source Type: research
Reply Letter - Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?
Eur Rev Med Pharmacol Sci. 2022 May;26(9):3061. doi: 10.26355/eurrev_202205_28722.NO ABSTRACTPMID:35587055 | DOI:10.26355/eurrev_202205_28722 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - May 19, 2022 Category: Drugs & Pharmacology Authors: J F de Carvalho L C Behrmann Martins A F Cardoso Y Shoenfeld Source Type: research
Co-occurrence of relapsing polychondritis and autoimmune thyroid diseases
Relapsing polychondritis (RP) is a rare inflammatory disease characterized by recurrent inflammation and destruction of cartilaginous tissues. RP has characteristics of autoimmune disease and some reports have... (Source: Orphanet Journal of Rare Diseases)
Source: Orphanet Journal of Rare Diseases - May 10, 2022 Category: Internal Medicine Authors: Toshiki Nakajima, Hajime Yoshifuji, Yoshihisa Yamano, Kimiko Yurugi, Yasuo Miura, Taira Maekawa, Tsuneyasu Yoshida, Hiroshi Handa, Koichiro Ohmura, Tsuneyo Mimori and Chikashi Terao Tags: Research Source Type: research
Relapsing polychondritis with multiple neurologic manifestations
(Source: Acta Neurologica Belgica)
Source: Acta Neurologica Belgica - May 5, 2022 Category: Neurology Source Type: research
Relapsing polychondritis revealed by < sup > 18 < /sup > F-FDG and Al < sup > 18 < /sup > F-NOTA-FAPI-04 PET/CT
Hell J Nucl Med. 2022 Apr 8:s002449912441. doi: 10.1967/s002449912441. Online ahead of print.NO ABSTRACTPMID:35388809 | DOI:10.1967/s002449912441 (Source: Hellenic Journal of Nuclear Medicine)
Source: Hellenic Journal of Nuclear Medicine - April 7, 2022 Category: Nuclear Medicine Authors: Ming Ni Qiang Xie Xingxing Zhu Weifu Lv Source Type: research
